IPO registrations (S-1, F-1) · Registrants
ENDOLOGIX INC /DE/
- SEC CIK
- 1013606 · filings on EDGAR ↗
- Name on the registration
- CARDIOVASCULAR DYNAMICS INC
- Former names
- RADIANCE MEDICAL SYSTEMS INC /DE/ (1999–2002); CARDIOVASCULAR DYNAMICS INC (1996–1999)
- Registration
- Form S-1, first filed 1996-05-17, last 1997-06-13; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 1996-06-20
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 2 MUSICK, Irvine, CA 92618
- EIN
- 68-0328265
- EDGAR entity type
- operating
- Insiders and CEO pay
- ENDOLOGIX INC /DE/ on the corporate pages
Offering terms
- Proposed price range
- $11.00–$13.00 per share (S-1/A filed 1996-06-19)
- Final price
- $12.00 per share, within the range (424B1 filed 1996-06-20, an initial public offering)
- Shares sold
- 3,400,000
- Gross proceeds
- $40,800,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CCVD
- Lead underwriters
- Volpe, Welty & Company (850,000 shares); Wessels, Arnold & Henderson (850,000 shares); Vector Securities International, Inc (850,000 shares)
- Syndicate
- Alex. Brown & Sons (100,000); Hambrecht & Quist (100,000); Montgomery Securities (100,000); Piper Sandler (100,000); UBS (100,000); Cruttenden Roth, Inc (50,000); Dain Bosworth Incorporated (50,000); Fahnestock & Co. Inc (50,000); Gerard Klauer Mattison & Co., LLC (50,000); Needham & Company (50,000); Pennsylvania Merchant Group Ltd (50,000); Sanders Morris Mundy Inc (50,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ENDOLOGIX, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: ENDOLOGIX LLC EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: ENDOLOGIX LLC EXACT (EIN (EXACT))
- Form D issuer: ENDOLOGIX INC /DE/ EXACT (CIK (EXACT))
- SEC filer: ENDOLOGIX INC /DE/ EXACT (CIK (EXACT))
- Person page: Guido J Neels Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Leslie V Norwalk Jd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1996-05-17 | S-1/A | S-1/A (amendment) | CARDIOVASCULAR DYNAMICS INC | 0000892569-96-000738 ↗ |
| 1996-06-10 | S-1/A | S-1/A (amendment) | CARDIOVASCULAR DYNAMICS INC | 0000891618-96-000816 ↗ |
| 1996-06-19 | S-1/A | S-1/A (amendment) | CARDIOVASCULAR DYNAMICS INC | 0000891618-96-000929 ↗ |
| 1996-06-20 | 424B1 | 424B1 (final prospectus) | CARDIOVASCULAR DYNAMICS INC | 0000891618-96-000950 ↗ |
| 1996-11-12 | S-1 | S-1 (registration) | CARDIOVASCULAR DYNAMICS INC | 0000891618-96-002622 ↗ |
| 1996-11-29 | S-1MEF | S-1MEF (added securities) | CARDIOVASCULAR DYNAMICS INC | 0000891618-96-002946 ↗ |
| 1997-06-13 | S-1 | S-1 (registration) | CARDIOVASCULAR DYNAMICS INC | 0000891618-97-002601 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1996-06-19 | S-1/A | registration statement | $11.00–$13.00 | 3,400,000 | - | Nasdaq CCVD | 3 | from the submission text; range, shares headline, cover names 3 | document ↗ | |
| 1996-06-20 | 424B1 | final prospectus | $12.00 | 3,400,000 | $40,800,000 | Nasdaq CCVD | 15 | from the submission text; price sentence, shares headline, proceeds computed, underwriting table 15, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Krist Robert John | Officer | Chief Financial Officer | 19 | 2006–2012 | |
| BROWN FRANKLIN D | Director | 14 | 2006–2011 | ||
| Coelyn Ronald H | Director | 2 | 2006–2007 | ||
| DE GREEF RODERICK | Director | 13 | 2006–2013 | ||
| DIETHRICH EDWARD | Director | 3 | 2006–2008 | ||
| MCCORMICK PAUL | Director; Director,Officer | Chief Executive Officer & Pres | 8 | 2006–2010 | |
| ODONNELL JEFFREY F | Director | 9 | 2006–2010 | ||
| SCHRECK STEFAN | Officer | Vice President | 19 | 2006–2013 | |
| UYESUGI KAREN | Officer | Vice President | 5 | 2006–2007 | |
| WALLER GREGORY D | Director | 29 | 2006–2020 | ||
| ELLIOTT ASSOCIATES, L.P. | TenPercentOwner | 29 | 2006–2010 | ||
| ELLIOTT INTERNATIONAL, L.P. | TenPercentOwner | 29 | 2006–2010 | ||
| Fauls Janet Mary | Officer | Vice President RA/QA/QC; VP Regulatory Affairs | 13 | 2007–2015 | |
| McDermott John D | Director; Director,Officer | Chief Executive Officer | 39 | 2008–2018 | |
| DeJohn Joseph A. | Officer | General Manager, Asia & Pac; Vice President - Sales; VP- Global Sales | 17 | 2008–2016 | |
| Sorsher Gary I. | Officer | Vice President - Quality | 14 | 2008–2013 | |
| Hawkins Daniel | Officer | Vice Pres - Global Marketing | 2 | 2009 | |
| Lemaitre Dan | Director | 18 | 2009–2020 | ||
| Tyler Martin | Officer | V.P. Global Marketing; VP, International | 12 | 2010–2013 | |
| Wilder Thomas | Director | 21 | 2010–2020 | ||
| Abraham Todd | Officer | VP of Operations | 14 | 2010–2015 | |
| Mitchell Robert D | Officer | President; President, Global Initiatives; President, International | 29 | 2010–2017 | |
| NEELS GUIDO J | Director | 15 | 2010–2019 | person page Fuzzy | |
| Greenstein Leonard M. | Officer | VP Finance & Corp Controller | 8 | 2011–2013 | |
| Lyons Ruth Anne | Officer | VP Global Marketing | 5 | 2011–2014 | |
| ESSEX WOODLANDS HEALTH VENTURES FUND VII LP | TenPercentOwner | 4 | 2012 | ||
| Love Charles Steele | Officer | VP-Clinical Affairs | 10 | 2012–2016 | |
| Thunen Shelley B | Officer; Other | Chief Financial Officer | 7 | 2013–2015 | |
| Zenty III Thomas F | Director | 12 | 2013–2019 | ||
| Jennings David M. | Officer | VP-Human Resources | 7 | 2013–2016 | |
| Machek James Edward | Officer | VP-Research & Development | 14 | 2013–2016 | |
| Lima Jose A. | Officer | VP-Quality | 12 | 2014–2016 | |
| DePalma Amanda L. | Officer | VP, Global Marketing | 4 | 2014–2016 | |
| Norwalk Leslie V | Director | 7 | 2015–2019 | person page Fuzzy | |
| Ferracci Cecile | Officer | General Manager, Europe | 2 | 2015–2016 | |
| Mahboob Vaseem | Officer | Chief Financial Officer; VP, Quality | 19 | 2015–2020 | |
| Chavez Christopher G. | Director | 6 | 2016–2018 | ||
| Chobotov Michael V. | Officer | Chief Technology Officer | 5 | 2016 | |
| O'Quinn Shari L | Officer | VP, Clinical & Regulatory | 5 | 2016–2017 | |
| Nagel Laura | Officer | VP, Quality | 2 | 2017–2018 | |
| Onopchenko John | Director,Officer; Officer | CEO and Director; Chief Executive Officer; Chief Operating Officer | 13 | 2017–2020 | |
| Camber Capital Management LLC | TenPercentOwner | 2 | 2018 | ||
| HAYDEN JEREMY B. | Officer | General Counsel | 6 | 2018–2019 | |
| Thompson Matthew | Officer | Chief Medical Officer | 11 | 2018–2020 | |
| Fecho Jeff | Officer | Chief Quality Officer | 6 | 2019–2020 | |
| Zehren John | Officer | Chief Commercial Officer | 3 | 2019–2020 | |
| Kiernan Jane E | Director | 2 | 2020 | ||
| MOTT RICHARD W | Director | 1 | 2020 | ||
| Brady Timothy Nicholas | Officer | Controller and Corp Secretary | 3 | 2020 | |
| Pinto Cynthia Buch | Officer | Interim CFO | 5 | 2020 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-08-22 | ENDOLOGIX INC /DE/ | Other Health Care | $210,500,000 | $210,500,000 | 3 | 1 |
| 2017-04-07 | ENDOLOGIX INC /DE/ | Other Health Care | $179,718,100 | $179,718,100 | 4 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ENDOLOGIX, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | ENDOLOGIX LLC | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | ENDOLOGIX INC /DE/ | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | ENDOLOGIX INC /DE/ | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | ENDOLOGIX LLC | EIN (EXACT) | ||
| Person page | Guido J Neels | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Leslie V Norwalk Jd | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, CA first:
- FUSION MEDICAL TECHNOLOGIES INC CA
- CEMAX ICON INC CA
- TRYLON CORP CA
- R2 TECHNOLOGY INC CA
- CERUS CORP CA
- SOMNUS MEDICAL TECHNOLOGIES INC CA
- MICRUS ENDOVASCULAR CORP CA
- AEROGEN INC CA
- IOMED LLC CA
- Adynxx, Inc. CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology